Hemostatic Mechanisms and Metastasis: Developments in Oncology, cartea 22
Editat de Kenneth V. Honn, Bonnie F. Sloaneen Limba Engleză Hardback – 31 iul 1984
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1389.90 lei 43-57 zile | |
Springer Us – 13 oct 2011 | 1389.90 lei 43-57 zile | |
Hardback (1) | 1396.84 lei 43-57 zile | |
Springer Us – 31 iul 1984 | 1396.84 lei 43-57 zile |
Din seria Developments in Oncology
- 5% Preț: 353.45 lei
- 5% Preț: 377.07 lei
- 5% Preț: 345.71 lei
- 5% Preț: 1074.75 lei
- 5% Preț: 353.62 lei
- 5% Preț: 1103.07 lei
- 5% Preț: 3118.93 lei
- 5% Preț: 363.85 lei
- 5% Preț: 367.04 lei
- 5% Preț: 1389.15 lei
- 5% Preț: 367.79 lei
- 5% Preț: 361.17 lei
- 5% Preț: 1079.77 lei
- 5% Preț: 360.97 lei
- 15% Preț: 592.33 lei
- 5% Preț: 1096.43 lei
- 5% Preț: 367.04 lei
- 5% Preț: 1387.38 lei
- 5% Preț: 708.59 lei
- 5% Preț: 698.91 lei
- 5% Preț: 1395.26 lei
- 5% Preț: 704.13 lei
- 5% Preț: 360.26 lei
- 5% Preț: 1394.36 lei
- 5% Preț: 1075.45 lei
- 5% Preț: 3758.19 lei
- 5% Preț: 1078.35 lei
- 5% Preț: 1086.60 lei
- 5% Preț: 1390.62 lei
- 5% Preț: 1410.11 lei
- 5% Preț: 1092.13 lei
Preț: 1396.84 lei
Preț vechi: 1470.36 lei
-5% Nou
Puncte Express: 2095
Preț estimativ în valută:
267.33€ • 277.68$ • 222.05£
267.33€ • 277.68$ • 222.05£
Carte tipărită la comandă
Livrare economică 03-17 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780898386677
ISBN-10: 0898386675
Pagini: 432
Ilustrații: XXII, 432 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.82 kg
Ediția:1984
Editura: Springer Us
Colecția Springer
Seria Developments in Oncology
Locul publicării:New York, NY, United States
ISBN-10: 0898386675
Pagini: 432
Ilustrații: XXII, 432 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.82 kg
Ediția:1984
Editura: Springer Us
Colecția Springer
Seria Developments in Oncology
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1. Is there Clinical Relevance for Therapies which Disrupt the Metastatic Cascade?.- 2. Overview of the Metastatic Cascade.- 3. Overview on Blood Coagulation Proteins.- 4. The Microinjury Hypothesis and Metastasis.- 5. Hemostatic Abnormalities in Tumor-Bearing Animals.- 6. Evidence for a Tumor Proteinase in Blood Coagulation.- 7. Relationship between Procoagulant Activity and Metastatic Capacity of Tumor Cells.- 8. Fibrin Formation: Implications for Tumor Growth and Metastasis.- 9. Perspectives on the Role of Platelets in Hemostasis and Thrombosis.- 10. Mechanisms of Platelet Aggregation by Murine Tumor Cell Spheroids.- 11. Heterogenous Mechanisms of Tumor Cell-Induced Platelet Aggregation with Possible Pharmacological Strategy Toward Prevention of Metastases.- 12. Tumor Cysteine Proteinases, Platelet Aggregation and Metastasis.- 13. Arachidonate Metabolism in Platelets and Blood Vessels.- 14. Prostacyclin/Thromboxanes and Tumor Cell Metastasis.- 15. Evidence for Altered Arachidonic Acid Metabolism in Tumor Metastasis.- 16. Calcium Channel Blockers: Inhibitors of Tumor Cell-Platelet-Endothelial Cell Interactions.- 17. Evidence for the Antimetastatic Effects of Coumarin Derivatives.- 18. Mitogenic Stimulation of Tumor Cells by Platelet Derived Growth Factors.- 19. Role of the Vascular Endothelium in Hemostasis.- 20. The Cellular Interactions of Metastatic Tumor Cells with Special Reference to Endothelial Cells and their Basal Lamina-Like Matrix.- 21. Interaction of Tumor Cells with the Basement Membrane of Endothelium.- 22. Hemostatic Alterations in Cancer Patients.- 23. Historical Overview of Clinical Experience with Anticoagulant Therapy.- 24. Rationale for Anticoagulant Treatment of Cancer.- 25. The Design and Execution of Anticoagulant Therapy Trials in Cancer.- 26.Experimental and Clinical Experience with Pyrimido — Pyrimidine Derivatives in the Inhibition of Malignant Metastasis Formation.- 27. Current Clinical Trials with Anticoagulant Therapy in the Management of Cancer Patients.